TL;DR
A comprehensive literature search was conducted using search engines like Google Scholar, Scopus, and PubMed to explore the effects of GLP-1 receptor agonists in tumor suppression and regression and found combination therapy of exendin-4 with gemcitabine may be beneficial in pancreatic cancer.
AI-generated by Semantic Scholar
Authors
Baseer ASLAM, Muhammad D. BIN ZAFAR, Mah I Kan CHANGEZ, Muhammad ABDULLAH, Muhammad SAFWAN, Bisma QAMAR, Abdullah SHINWARI, Sanjana RAI
